selected publications
-
Phase I trial of sorafenib following liver transplantation in patients with high-risk hepatocellular carcinoma.
Liver cancer.
2015
Academic Article
GET IT
Times cited: 15 -
Randomized trial comparing dose reduction and growth factor supplementation for management of hematological side effects in HIV/hepatitis C virus patients receiving pegylated-interferon and ribavirin.
Journal of acquired immune deficiency syndromes (1999).
2011
Academic Article
GET IT
Times cited: 10 -
Smoking and hepatocellular carcinoma mortality.
Experimental and therapeutic medicine.
2011
Academic Article
GET IT
Times cited: 9 -
Obesity and microvascular invasion in hepatocellular carcinoma.
Cancer investigation.
2010
Academic Article
GET IT
Times cited: 26